For the test for determining VEGF-R2 and FGF-2 in glioma, a decrease in the concentration of the measured protein will indicate the disease because the direction of the diagnostic variable for these tests is decreasing (indicating a destimulant). Here, FGF2 is linked to central nervous system cancer.